InvestorsHub Logo
Followers 8
Posts 585
Boards Moderated 0
Alias Born 11/03/2014

Re: Waverunner1 post# 120851

Thursday, 09/03/2015 5:04:10 PM

Thursday, September 03, 2015 5:04:10 PM

Post# of 403482
I would add that a mid/late Phase 2 deal on K (AML or solid tumors) could potentially get us there sooner, depending on how impressive those early results are (and assuming a successful deal on B prior to that point).

I agree on the 3 to 4 yr timeline to reach that kind of valuation (north of $10B) but I think the odds greatly favor a deal on B inside 12-18 mos and that would result in a large step increase potentially in the range of 10X the current valuation. Ultimately, B valuation will of course depend in part on the level of success in the OM trial. In the interim I don't think it would be too hard to get into the $6-$8 range on uplist and addition to the various Russell indices next June if accompanied by continued positive trial results.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News